Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tavneos
Pharma
NEJM retracts article on pivotal study for Amgen’s Tavneos
As Tavneos comes under intensifying pressure, Amgen faces a new hurdle with a leading medical journal’s retraction of the drug’s pivotal study data.
Eric Sagonowsky
Jun 30, 2026 10:57am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
Amgen to file 3rd-party review of Tavneos data for FDA hearing
Jun 12, 2026 11:12am
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
May 22, 2026 8:53am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
FDA takes first steps in withdrawing approval of Amgen's Tavneos
Apr 28, 2026 11:37am
